Related Experiment Video
Updated: Oct 7, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis
Karol Bielski1,2, Katarzyna Makowska3, Adam Makowski3
1Research Unit, Polonia University, Czestochowa, Poland.
Insights
The coronavirus disease 2019 (COVID-19) pandemic did not significantly alter in-hospital cardiac arrest (IHCA) outcomes. However, patients with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection experienced worse IHCA outcomes, including lower return of spontaneous circulation and higher mortality.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic has raised concerns regarding its impact on various medical outcomes.
- In-hospital cardiac arrest (IHCA) is a critical event with significant morbidity and mortality.
- Understanding the influence of the pandemic and SARS-CoV-2 infection on IHCA is crucial for clinical management.
Purpose of the Study:
- To provide an updated meta-analysis on the effects of the COVID-19 pandemic on IHCA outcomes.
- To specifically investigate the impact of SARS-CoV-2 infection on IHCA survival and success rates.
Main Methods:
- This meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Comparative analyses were performed for pre- and intra-COVID-19 periods.
- Outcomes were compared between SARS-CoV-2 positive and negative patients.
Main Results:
- No statistically significant differences were observed in shockable rhythms, return of spontaneous circulation (ROSC), 30-day mortality, or overall mortality between pre- and intra-COVID-19 periods.
- Patients with SARS-CoV-2 infection showed a significantly lower incidence of shockable rhythms (9.6% vs. 19.8%) and ROSC (33.9% vs. 52.1%) compared to SARS-CoV-2 negative patients.
- SARS-CoV-2 positive patients had a statistically significant higher 30-day mortality (77.2% vs. 59.7%) and a trend towards higher overall mortality (94.9% vs. 76.7%).
Conclusions:
- The COVID-19 pandemic itself did not lead to statistically significant changes in IHCA outcomes when comparing pre- and intra-pandemic periods.
- SARS-CoV-2 infection is associated with poorer IHCA outcomes, characterized by reduced ROSC and increased mortality.
- These findings highlight the detrimental effect of SARS-CoV-2 on cardiac arrest resuscitation efforts and patient survival.
Background:
The main purposes of this meta-analysis are to update the information about the impact of coronavirus disease 2019 (COVID-19) pandemic on outcomes of in-hospital cardiac arrest (IHCA) and to investigate the impact of being infected by by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) on IHCA outcomes.
Methods:
The current meta-analysis is an update and follows the recommendations of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Results:
In analyses, pre- and intra-COVID-19 periods were observed for: shockable rhythms in 17.6% vs. 16.2% (odds ratio [OR]: 1.11; 95% confidence interval [CI]: 0.71-1.72; p = 0.65), return of spontaneous circulation (ROSC) in 47.4% vs. 44.0% (OR: 1.36; 95% CI: 0.90-2.07; p = 0.15), 30-day mortality in 59.8% vs. 60.9% (OR: 0.95; 95% CI: 0.75-1.22; p = 0.69) and overall mortality 75.8% vs. 74.7% (OR: 0.80; 95% CI: 0.49-1.28; p = 0.35), respectively. In analyses, SARS-CoV-2 positive and negative patients were observed for: shockable rhythms in 9.6% vs. 19.8% (OR: 0.51; 95% CI: 0.35-0.73; p < 0.001), ROSC in 33.9% vs. 52.1% (OR: 0.47; 95% CI: 0.30-0.73; p < 0.001), 30-day mortality in 77.2% vs. 59.7% (OR: 2.08; 95% CI: 1.28-3.38; p = 0.003) and overall mortality in 94.9% vs. 76.7% (OR: 3.20; 95% CI: 0.98-10.49; p = 0.05), respectively.
Conclusions:
Despite ROSC, 30-day and overall mortality rate were not statistically different in pre- vs. intra-COVID-19 periods, a lower incidence of ROSC and higher 20-day mortality rate were observed in SARS-CoV-2 (+) compared to SARS-CoV-2 (-) patients.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation I: Adult
Introduction Cardiac Emergencies
Acute Coronary Syndrome III: Diagnostic Studies

